Intermediate-dose (25mg/m2) IV melphalan for multiple myeloma with renal failure. [electronic resource]
Producer: 20030327Description: 684-9 p. digitalISSN:- 1121-8428
- Adult
- Aged
- Cohort Studies
- Dose-Response Relationship, Drug
- Drug Administration Schedule
- Female
- Humans
- Infusions, Intravenous
- Male
- Maximum Tolerated Dose
- Melphalan -- administration & dosage
- Middle Aged
- Multiple Myeloma -- complications
- Pilot Projects
- Probability
- Prognosis
- Prospective Studies
- Renal Insufficiency -- complications
- Risk Assessment
- Severity of Illness Index
- Survival Analysis
- Treatment Outcome
No physical items for this record
Publication Type: Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.